ANVISA registration

UROVYSION BLADDER CANCER RECURRENCE KIT

Registration 10055311129. ANTÍGENO ASSOCIADO AO TUMOR DE BEXIGA

Registration details

Registration number10055311129
Application number25351001676200312
Technical nameANTÍGENO ASSOCIADO AO TUMOR DE BEXIGA
Risk classIII
Published on25/04/2003
ValidityValid until 25/04/2033

Registration holder

Legal nameABBOTT LABORATORIOS DO BRASIL LTDA
CNPJ56.998.701/0001-16

Manufacturer

  • ABBOTT MOLECULAR INC ESTADOS UNIDOS DA AMÉRICA

Other registrations held by ABBOTT LABORATORIOS DO BRASIL LTDAview all

EQUIPO COM LANCETA PARA BOMBA DE NUTRICAO ENTERAL FLEXIFLO PATROL

10055310548

BOMBA PARA NUTRICAO ENTERAL FLEXIFLO PATROL

10055310571

SONDA NASOENTERAL FLEXIFLO 8Fr-10Fr-12Fr

10055310572

CN-Free Hemoglobin Reagent

10055310721

DILUENT/SHEATH CD Sapphire and CD Ruby

10055310743

WBC REAGENT PART B

10055310785

Source: ANVISA

Source: ANVISA open data, medical device file, updated daily. The public database provides registration validity, rather than registration status: this registration may have been cancelled before its expiry date without this being shown here. Before making purchasing, import or marketing decisions, check the ANVISA search portal.

Next step

Medical device registration with ANVISA

HSC manages the process from risk classification to liaising with the regulator, in Brazil and more than 40 other countries.

Speak to a specialist